Recently, a novel component-derivative of Mito-CP, a pyrroline nitroxide attached dyphenylphosphine compound, HO-5114, was synthesized [15], which demonstrated markedly higher cytotoxicity against TNBC and hormone receptor positive human breast cancer (HR+BC) lines than Mito-CP. This evidence concerns the gene NR4A1 and breast carcinoma.